107 related articles for article (PubMed ID: 12459647)
1. Microsatellite analysis in cutaneous malignant melanoma.
Massi D; Sardi I; Urso C; Franchi A; Borgognoni L; Salvadori A; Giannini A; Reali UM; Santucci M
Melanoma Res; 2002 Dec; 12(6):577-84. PubMed ID: 12459647
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability and alterations of mismatch repair protein expression in choroidal melanomas.
Hussein MR; Haemel AK; Albert DM; Wood GS
Arch Ophthalmol; 2005 Dec; 123(12):1705-11. PubMed ID: 16344443
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability and loss of heterozygosity in melanoma.
Peris K; Keller G; Chimenti S; Amantea A; Kerl H; Höfler H
J Invest Dermatol; 1995 Oct; 105(4):625-8. PubMed ID: 7561170
[TBL] [Abstract][Full Text] [Related]
4. Genotypic analysis of primary and metastatic cutaneous melanoma.
Rao UN; Jones MW; Finkelstein SD
Cancer Genet Cytogenet; 2003 Jan; 140(1):37-44. PubMed ID: 12550756
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of allelic deletions within melanoma metastases.
Bogdan I; Xin H; Burg G; Böni R
Melanoma Res; 2001 Aug; 11(4):349-54. PubMed ID: 11479423
[TBL] [Abstract][Full Text] [Related]
6. Instability of microsatellites is an infrequent event in uveal melanoma.
Cross NA; Murray AK; Rennie IG; Ganesh A; Sisley K
Melanoma Res; 2003 Oct; 13(5):435-40. PubMed ID: 14512784
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
[TBL] [Abstract][Full Text] [Related]
8. 9p21 deletions in primary melanoma.
Naylor MF; Brown S; Quinlan C; Pitha JV; Evertt MA
Dermatol Online J; 1997 Dec; 3(2):1. PubMed ID: 9452367
[TBL] [Abstract][Full Text] [Related]
9. Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma.
Birindelli S; Tragni G; Bartoli C; Ranzani GN; Rilke F; Pierotti MA; Pilotti S
Int J Cancer; 2000 Apr; 86(2):255-61. PubMed ID: 10738254
[TBL] [Abstract][Full Text] [Related]
10. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.
Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G
Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300
[TBL] [Abstract][Full Text] [Related]
11. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite DNA analysis does not distinguish malignant from benign pleural effusions.
Economidou F; Tzortzaki EG; Schiza S; Antoniou KM; Neofytou E; Zervou M; Lambiri I; Siafakas NM
Oncol Rep; 2007 Dec; 18(6):1507-12. PubMed ID: 17982637
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi.
Hussein MR; Sun M; Tuthill RJ; Roggero E; Monti JA; Sudilovsky EC; Wood GS; Sudilovsky O
J Cutan Pathol; 2001 Aug; 28(7):343-50. PubMed ID: 11437939
[TBL] [Abstract][Full Text] [Related]
14. High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma.
Alvino E; Marra G; Pagani E; Falcinelli S; Pepponi R; Perrera C; Haider R; Castiglia D; Ferranti G; Bonmassar E; Jiricny J; Zambruno G; D'Atri S
J Invest Dermatol; 2002 Jan; 118(1):79-86. PubMed ID: 11851879
[TBL] [Abstract][Full Text] [Related]
15. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
[TBL] [Abstract][Full Text] [Related]
16. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
[TBL] [Abstract][Full Text] [Related]
17. Mutations of p16 and p15 tumor suppressor genes and replication errors contribute independently to the pathogenesis of sporadic malignant melanoma.
Matsumura Y; Nishigori C; Yagi T; Imamura S; Takebe H
Arch Dermatol Res; 1998 Apr; 290(4):175-80. PubMed ID: 9617435
[TBL] [Abstract][Full Text] [Related]
18. Detection of loss of heterozygosityat microsatellite loci in esophageal squamous-cell carcinoma.
Ikeguchi M; Unate H; Maeta M; Kaibara N
Oncology; 1999; 56(2):164-8. PubMed ID: 9949304
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas.
Hussein MR; Sun M; Roggero E; Sudilovsky EC; Tuthill RJ; Wood GS; Sudilovsky O
Mol Carcinog; 2002 May; 34(1):35-44. PubMed ID: 12112321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
